Fact CheckerSign in

NCT07257146Enrolling by invitation

Smart-SABI: Digital Phenotyping of Stroke Access Barriers

Machine Learning Identification of Modifiable Access Barriers in Acute Ischemic Stroke: A Multimodal "Digital Phenotyping" Approach

Source: ClinicalTrials.gov · Last updated 2 Dec 2025

Brief summary (registry, in English)

This study aims to identify and quantify the non-clinical barriers (social, transport, and knowledge-based) that delay patient arrival at the hospital during an Acute Ischemic Stroke. By utilizing a multimodal approach that combines a validated patient questionnaire (SABI Tool), Geographic Information Systems (GIS) analysis, and biological markers (infarct volume), the investigators seek to develop a Machine Learning model capable of predicting high-risk phenotypes for pre-hospital delay. The ultimate goal is to validate "Social Determinants of Health" against objective biological outcomes.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
250 (estimated)
First submitted
20 Nov 2025
Start date
11 Oct 2025
Primary completion date
11 Feb 2027
Lead sponsor
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Diseases
Stroke
NCT number
NCT07257146

What you commit to

  • Study type: Observational
  • Planned participants: 250
  • From 11 Oct 2025 to the primary completion date, 11 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • In-hospital stroke onset. Stroke mimics (e.g., seizure, complex migraine, hypoglycemia). Hemorrhagic stroke. Homelessness or lack of fixed address (precludes geospatial analysis). Severe aphasia or cognitive deficit without an available surrogate/caregiver to complete the questionnaire.

Who the study is looking for

  • Diagnosis of Acute Ischemic Stroke (AIS) confirmed by neuroimaging (CT or MRI). Age $\\geq$ 18 years. Presentation to the Emergency Department within 7 days of symptom onset (to ensure recall accuracy).
    • Patient or Legally Authorized Representative (LAR) able to provide informed consent.
    • Verifiable residential address (required for GIS analysis).

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alexandria Stroke and Neurointervention Center
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.